Brought to you by:
Philips issues Class I recall for Tack endovascular system
Philips has recently announced that it will no longer sell its Tack endovascular system in the U.S. following a Class I recall issued by the Food and Drug Administration (FDA). A Class I recall is the FDA’s most serious classification,…
Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular fields
Stereotaxis has announced a Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic magnetic navigation into the broader endovascular field. Emagin 5F is the first in a family of robotically…
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the U.S. launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross narrowed vessels in patients with peripheral artery disease (PAD). The platform is designed to modify calcium…
‘Battlefield first aid’: A peer-to-peer prescription for dealing with adverse surgical outcomes
“Battlefield first aid” after a colleague has a bad case as the cornerstone of peer-to-peer support in vascular surgery was the feature of the recent Jesse E. Thompson, MD, Distinguished Guest Lecture at the 2025 Southern Association for Vascular Surgery…
AVF: From good to great
Ruth Bush, MD, used her 2025 American Venous Forum (AVF) presidential address to highlight the organization’s elevation and path to “level 5 leadership.” Level 5 leadership is seen across the organization’s activities, the University of Texas Medical Branch, Galveston, professor…
Open surgery, endovascular intervention and robotics: The coming ‘third revolution’ in vascular surgery
The 2025 Southern Association for Vascular Surgery (SAVS) presidential address featured the hashtag phrase #OnlyUs, an allusion to the specialty’s “unique” differentiator. SAVS 2024–25 President Alan Lumsden, MD, returned to a familiar recent theme for his address to the 49th…
AVF 2025: A call for ‘second-generation steps’ in venous stenting
The need for a revolutionary second generation of venous stents are among the gaps and unmet needs currently at play in deep venous surgery, the 2025 American Venous Forum (AVF), held from Feb. 16–19 in Atlanta, Georgia, heard. Erin Murphy…
Ketamine reduces postoperative opiate use and pain scores as part of spinal cord protection protocol for TAAA repair
The introduction of ketamine into a spinal cord ischemia (SCI) protection protocol used during thoracoabdominal aortic aneurysm (TAAA) repairs led to significant reductions in postoperative opiate administration and patient-reported pain scores, a randomized controlled trial (RCT) performed by a team…
FFRCT diagnosis of coronary ischemia with ischemia-targeted coronary revascularization more than halves five-year risk of cardiac death and MI following CEA
Preoperative diagnosis of lesion-specific ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFRCT) and ischemia-targeted coronary revascularization after carotid endarterectomy (CEA) can reduce the five-year risk of cardiac death and myocardial infarction (MI) by more than 50% and improve…
Humacyte announces commercial launch of Symvess for extremity vascular trauma
Humacyte today announced the commercial launch of Symvess (acellular tissue engineered vessel-tyod) for use in adults as a vascular conduit for extremity arterial injury when urgent revascularisation is needed to avoid imminent limb loss, and when autologous vein graft is…